{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:14:16Z","timestamp":1761128056336},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,10,30]],"date-time":"2003-10-30T00:00:00Z","timestamp":1067472000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1007\/s00296-003-0398-9","type":"journal-article","created":{"date-parts":[[2004,3,19]],"date-time":"2004-03-19T15:29:40Z","timestamp":1079710180000},"page":"42-44","source":"Crossref","is-referenced-by-count":37,"title":["Serum homocysteine level is higher in Beh\u00e7et\u2019s disease with vascular involvement"],"prefix":"10.1007","volume":"25","author":[{"given":"A\u015fk\u0131n","family":"Ate\u015f","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olcay","family":"Ayd\u0131ntu\u011f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00dcmit","family":"\u00d6lmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur\u015fen","family":"D\u00fczg\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Duman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,10,30]]},"reference":[{"key":"398_CR1","doi-asserted-by":"crossref","unstructured":"Ayd\u0131ntu\u011f AO (2001) Vascular manifestations in Beh\u00e7et\u2019s disease. In: Asherson RA, Cervera R (eds) Vascular manifestations of systemic autoimmune diseases. CRC, Boca Raton, pp\u00a0361\u2013373","DOI":"10.1201\/9781420040395.ch25"},{"key":"398_CR2","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/ard.60.12.1081","volume":"60","author":"Leiba","year":"2001","unstructured":"Leiba M, Sidi Y, Gur H, Leiba A, Ehrenfeld M (2001) Beh\u00e7et\u2019s disease and thrombophilia. Ann Rheum Dis 60:1081\u20131085","journal-title":"Ann Rheum Dis"},{"key":"398_CR3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(98)11058-9","volume":"354","author":"Hankey","year":"1999","unstructured":"Hankey GJ, Eikelboom JW (1999) Homocysteine and vascular disease. Lancet 354:407\u2013413","journal-title":"Lancet"},{"key":"398_CR4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/labinvest.3780275","volume":"81","author":"Durand","year":"2001","unstructured":"Durand P, Prost M, Loreau N, Lussier-Cacan S, Blache D (2001) Impaired homocysteine metabolism and atherothrombotic disease. Lab Invest 81:645\u2013672","journal-title":"Lab Invest"},{"key":"398_CR5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/01.RES.84.4.409","volume":"84","author":"Dudman","year":"1999","unstructured":"Dudman NP, Temple SE, Guo XW, Fu W, Perry MA (1999) Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo. Circ Res 84:409\u2013416","journal-title":"Circ Res"},{"key":"398_CR6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM199603213341203","volume":"334","author":"den","year":"1996","unstructured":"den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, Vandenbroucke JP, Rosendaal FR (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334:759\u2013762","journal-title":"N Engl J Med"},{"key":"398_CR7","first-page":"1078","volume":"335","author":"International","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease (1990) Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"key":"398_CR8","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/rheumatology\/35.11.1178","volume":"35","author":"G\u00fcl","year":"1996","unstructured":"G\u00fcl A, \u00d6zbek U, \u00d6zt\u00fcrk C, \u0130nan\u00e7 M, Koni\u00e7e M, \u00d6z\u00e7elik T (1996) Coagulation factor V mutation increases the risk of venous thrombosis in Beh\u00e7et\u2019s disease. Br J Rheumatol 35:1178\u20131180","journal-title":"Br J Rheumatol"},{"key":"398_CR9","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/rheumatology\/38.12.1298","volume":"38","author":"G\u00fcl","year":"1999","unstructured":"G\u00fcl A, Aslantas AB, Tekinay T, Koni\u00e7e M, \u00d6z\u00e7elik T (1999) Procoagulant mutations and venous thrombosis in Beh\u00e7et\u2019s disease. Rheumatology 38:1298\u20131299","journal-title":"Rheumatology"},{"key":"398_CR10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-0038-1646409","volume":"66","author":"Hampton","year":"1991","unstructured":"Hampton KK, Chamberlain MA, Menon DK, Davis JA (1991) Coagulation and fibrinolytic activity in Beh\u00e7et\u2019s disease. Thromb Haemost 66:292\u2013294","journal-title":"Thromb Haemost"},{"key":"398_CR11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3109\/03009749509095184","volume":"24","author":"\u00d6zoran","year":"1995","unstructured":"\u00d6zoran K, D\u00fczg\u00fcn N, G\u00fcrler A, Tutkak H, Tokg\u00f6z G (1995) Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Beh\u00e7et\u2019s disease. Scand J Rheumatol 24:376\u2013382","journal-title":"Scand J Rheumatol"},{"key":"398_CR12","first-page":"2404","volume":"26","author":"Mader","year":"1999","unstructured":"Mader R, Ziv M, Adawi M, Mader R, Lavi I (1999) Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Beh\u00e7et\u2019s disease. J Rheumatol 26:2404\u20132408","journal-title":"J Rheumatol"},{"key":"398_CR13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/rheumatology\/40.6.687","volume":"40","author":"Aksu","year":"2001","unstructured":"Aksu K, Turgan N, Oksel F, Keser G, Ozmen D, Kitap\u00e7ioglu G, Gumusdis G, Bayindir O, Doganavsargil E (2001) Hyperhomocysteinaemia in Beh\u00e7et\u2019s disease. Rheumatology 40:687\u2013690","journal-title":"Rheumatology"},{"key":"398_CR14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0049-3848(02)00085-3","volume":"106","author":"Lee","year":"2002","unstructured":"Lee YJ, Kang SW, Yang JI, Choi YM, Sheen D, Lee EB, Choi SW, Song YW (2002) Coagulation parameters and plasma total homocysteine levels in Beh\u00e7et\u2019s disease. Thromb Res 106:19\u201324","journal-title":"Thromb Res"},{"key":"398_CR15","unstructured":"Korkmaz C, Bozan B, Kosar M, Sahin F, Gulbas Z (2002) Is there association of plasma homocysteine level with vascular involvement in patients with Beh\u00e7et\u2019s syndrome? Clin Exp Rheumatol 20 [Suppl\u00a026]:S30\u2013S34"},{"key":"398_CR16","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","volume":"274","author":"Boushey","year":"1995","unstructured":"Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274:1049\u20131057","journal-title":"JAMA"},{"key":"398_CR17","first-page":"1489","volume":"127","author":"Monnerat","year":"1997","unstructured":"Monnerat C, Hayoz D (1997) Homocysteine and venous thromboembolism. Schweiz Med Wochenschr 127:1489\u20131496","journal-title":"Schweiz Med Wochenschr"},{"key":"398_CR18","doi-asserted-by":"crossref","unstructured":"Harpel PC, Zhang X, Borth W (1996) Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis. J Nutr 126 [Suppl\u00a04]:1285\u20131289","DOI":"10.1093\/jn\/126.suppl_4.1285S"},{"key":"398_CR19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.ATV.18.3.356","volume":"18","author":"den","year":"1998","unstructured":"den Heijer M, Brouwer IA, Bos GMJ, Blom HJ, van der Put NMJ, Spaans AP, Rosendaal FR, Thomas CMG, Haak HL, Wijermans PW, Gerrits WBJ (1998) Vitamin supplementation reduces blood homocysteine levels. A controlled trial in patients with venous thrombosis and healthy volunteers. Arterioscler Thromb Vasc Biol 18:356\u2013361","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-003-0398-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-003-0398-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-003-0398-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:15:13Z","timestamp":1559042113000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-003-0398-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,30]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["398"],"URL":"https:\/\/doi.org\/10.1007\/s00296-003-0398-9","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,30]]}}}